In the last trading session, 13.2 million shares of the Conduit Pharmaceuticals Inc (NASDAQ:CDT) were traded, and its beta was 2.29. Most recently the company’s share price was $0.07, and it changed around $0.0 or -2.44% from the last close, which brings the market valuation of the company to $11.08M. CDT currently trades at a discount to its 52-week high of $3.92, offering almost -5500.0% off that amount. The share price’s 52-week low was $0.05, which indicates that the current value has risen by an impressive 28.57% since then. We note from Conduit Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 185.56 million shares, with the 3-month average coming to 51.55 million.
Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information
Instantly CDT has showed a red trend with a performance of -2.44% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.1128 on recent trading dayincreased the stock’s daily price by 37.94%. The company’s shares are currently up 4.96% year-to-date, but still down -41.61% over the last five days. On the other hand, Conduit Pharmaceuticals Inc (NASDAQ:CDT) is -2.57% down in the 30-day period. We can see from the shorts that 3.57 million shares have been sold at a short interest cover period of 0.14 day(s).
CDT Dividends
Conduit Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in February.
Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 49.12% of Conduit Pharmaceuticals Inc shares, and 4.06% of them are in the hands of institutional investors. The stock currently has a share float of 7.97%.
Fidelity Small Cap Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Oct 31, 2024 . The former held 233.35 shares worth $16801.0, making up 0.19% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 202.93 shares worth around $14611.0, which represents about 0.17% of the total shares outstanding.
